Back
PIMCO Corporate & Income Opportunity Fund Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Sell
48
PTY
PIMCO Corporate & Income Opportunity Fund
Last Price:
$12.90
Seasonality Move:
-0.06%
Sell
38
RAPT
Rapt Therapeutics, Inc.
Last Price:
$34.08
Seasonality Move:
-28.15%
Sell
48
PIMCO Corporate & Income Opportunity Fund (PTY)
is a Sell
Is PIMCO Corporate & Income Opportunity Fund a Buy, Sell or Hold?
-
The current PIMCO Corporate & Income Opportunity Fund [PTY] share price is $12.96. The Score for PTY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.38. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTY Stock Price Chart
What is PIMCO Corporate & Income Opportunity Fund's stock price today?
-
The PIMCO Corporate & Income Opportunity Fund share price today is $12.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.38The current trend is moderately bullish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.
PTY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.58 | Buy |
| Relative Strength Index (14 RSI): | 42.49 | Sell |
| Chaikin Money Flow: | 1827842 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.89 - 13.21) | Sell |
| Bollinger Bands (100): | (13.23 - 14.33) | Sell |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.71 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | -220916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.11 - 35.93) | Sell |
| Bollinger Bands (100): | (16.49 - 33.77) | Buy |
PTY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.89 | Buy |
| 20-day SMA: | 13.01 | Sell |
| 50-day SMA: | 13.31 | Sell |
| 200-day SMA: | 13.78 | Sell |
| 8-day EMA: | 11.17 | Buy |
| 20-day EMA: | 7.1 | Buy |
| 50-day EMA: | 3.53 | Buy |
| 200-day EMA: | 0.99 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.03 | Sell |
| 20-day SMA: | 34.65 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 31.26 | Buy |
| 20-day EMA: | 20.72 | Buy |
| 50-day EMA: | 10.54 | Buy |
| 200-day EMA: | 3 | Buy |
PIMCO Corporate & Income Opportunity Fund Earnings Growth & PTY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
PIMCO Corporate & Income Opportunity Fund Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||